Pharmacists Working in General Practice
Since 2019, as part of the NHS Long Term Plan pharmacists have been working in general practice settings where they can be employed directly by a GP practice or via the Primary Care Network (PCN). Funding for pharmacists employed in general practice can be accessed through the Additional Roles Reimbursement Scheme (ARRS).
Pharmacists in general practice provide support in delivering clinical services, this includes:
ensuring that patients are getting the best out of their medicines through effective patient education
carrying out holistic and comprehensive structured medication reviews using shared decision making and a patient centred approach
management of Long-Term Conditions (LTC) including asthma, COPD, diabetes, cardiovascular disease and chronic kidney disease (CKD)
management of polypharmacy, particularly in older patients and those living with frailty
working as part of the wider MDT to manage complex patients
reducing medication related harms and admission avoidance by identifying and managing inappropriate prescribing
Pharmacists provide support in effective medicines management which includes:
developing efficient and safe processes to manage acute prescription requests and repeat medications
oversight of high-risk drug monitoring
medication related audits
management of MHRA Drug Alerts
management of medicines that are out of stock
reducing medication waste due to oversupply or inappropriate medication requests
reducing the environmental impact of medicines
effective medicines reconciliation at point of transfer of care such as hospital discharge
Pharmacists provide leadership and support the practice in training and education related to safer, evidence-based and cost-effective prescribing by:
championing Antimicrobial Stewardship
providing accurate and evidence-based advice on prescribing best practice
advising on cost-effective recommendations and encouraging adherence to NCL formulary choices
providing therapeutic updates particularly when new medicines or treatments become available
providing clinical supervision to other clinical staff
acting as a role model and mentor
By employing pharmacists, many GP practices have:
improved access to appointments
reduced medication related harms and A&E admissions
improved screenings and diagnosis of chronic and common conditions
improved patient outcomes through medicines optimisation, effective medication monitoring and, timely and holistic medication reviews
reduced risks associated with transfer of care between healthcare settings
reduced medication costs
Watch the video below to find out more about the role and background of a pharmacist working in general practice.
Pharmacists employed in general practice through the ARRS are required to be enrolled onto a mandatory training pathway called the Primary Care Pharmacy Education Pathway (PCPEP) provided through the Centre for Pharmacy Postgraduate Education (CPPE). This prepares the pharmacist to work effectively in a primary care setting.
The PCPEP provides all pharmacists with the opportunity to be part of a professional clinical network
Pharmacists should be clinically supervised by a senior pharmacist as well as a GP clinical supervisor
Independent Prescribing qualification is in addition to the training pathway and is usually completed following completion of the PCPEP
Prerequisites:
Pharmacy degree (MPharm) and registration as a pharmacist with the General Pharmaceutical Council or the equivalent regulatory authority in your home country.
Course overview:
18-month pathway, including 28 days dedicated study days
Pharmacists receive a statement of assessment & progression (SOAP) on completion of the pathway
No placement is required as the pharmacist will be employed within primary care whilst completing the PCPEP
Benefits to patients:
Patients often get to consult with pharmacists for longer than a GP, e.g. 15–30 minutes, which they appreciate. This is of particularly value when managing LTCs such as diabetes where a multifactorial, holistic approach is required.
Medications are checked regularly and are appropriate for patients’ conditions. This reduces the likelihood of conditions worsening or leading to other complications and side effects that result in a future need for acute care. Ultimately, this improves wellbeing and quality of life for the patients
Reduced medication related harms due to efficient high-risk drug monitoring and effective management of potentially inappropriate medication (PIMs). This is particularly significant for older patients who are more vulnerable to medication effects
All prescribers in the practice can learn from the pharmacist and therefore use increasing medicines knowledge and expertise to improve patient treatment
Benefits to PCNs:
GPs no longer carry out the activities that pharmacists can carry out instead,
Pharmacists support the achievement of QOF and IIF indicators, local prescribing targets and quality improvement projects
Improvements in patient safety. Changes in prescribing practice that can be implemented across the PCN e.g. MHRA alerts where a drug is withdrawn or indications change
Considerable savings can be made by improving prescribing processes across all prescribing staff
Pharmacists forge closer links with community pharmacy and improve patient advice/signposting. All prescribers in the practice learn from the clinical pharmacist and therefore increase their own knowledge when consulting with and treating patients
Patient access increases as patients consult with the pharmacist rather than the GP for medication needs and advice
Benefits to the wider NHS:
Closer monitoring and management of patient medicines improves their care, wellbeing, and their ability to self-care and manage their own conditions. This reduces avoidable urgent or emergency hospital attendances specifically related to deterioration in LTCs and medicine-related harm
Closer MDT working and interprofessional networks improves patient outcomes, particularly in the management of LTCs, older patients and those living with frailty
Improved care at the point of transfer between care settings due to better interface working
Promotion of public health initiatives such as Live Well
Newly emerging prescribing pharmacists workforce
Initial education and training of pharmacists with integrated prescribing qualification
The NCL Training Hub is excited to announce a significant update regarding the transformational changes to the initial education and training of pharmacists (IETP). These changes will greatly impact the pharmacy workforce across primary care environments, including general practice and community pharmacy. In brief, this means that starting in August 2026, all newly qualified pharmacists will be Independent Prescribers upon registration. Please refer to the attached communication for an overview of these changes, along with useful actions for primary care employers to prepare adequately and support the pharmacy workforce during this transition.
Please use the attached recruitment pack and adapt it for your requirements.
This page has more content for members.
In order to access this content please register for an account with NCL Training Hub. By logging in as a registered user you will be able to access secure content here and elsewhere on the NCL Training Hub website
Log in Register